
### [MONDO:0001639](http://purl.obolibrary.org/obo/MONDO_0001639)
**Label:** deficiency anemia

**Subclasses:** [MONDO:0020109](http://purl.obolibrary.org/obo/MONDO_0020109) (constitutional megaloblastic anemia due to vitamin B12 metabolism disorder), [MONDO:0016623](http://purl.obolibrary.org/obo/MONDO_0016623) (rare deficiency anemia), [MONDO:0018964](http://purl.obolibrary.org/obo/MONDO_0018964) (homocystinuria without methylmalonic aciduria), [MONDO:0010298](http://purl.obolibrary.org/obo/MONDO_0010298) (Lesch-Nyhan syndrome), [MONDO:0016088](http://purl.obolibrary.org/obo/MONDO_0016088) (hypoxanthine-guanine phosphoribosyltransferase deficiency), [MONDO:0010185](http://purl.obolibrary.org/obo/MONDO_0010185) (methylmalonic aciduria and homocystinuria type cblD), [MONDO:0020111](http://purl.obolibrary.org/obo/MONDO_0020111) (constitutional megaloblastic anemia due to folate metabolism disorder), [MONDO:0020112](http://purl.obolibrary.org/obo/MONDO_0020112) (vitamin B12- and folate-independent constitutional megaloblastic anemia), [MONDO:0009852](http://purl.obolibrary.org/obo/MONDO_0009852) (congenital intrinsic factor deficiency), [MONDO:0020098](http://purl.obolibrary.org/obo/MONDO_0020098) (constitutional anemia due to iron metabolism disorder), [MONDO:0016826](http://purl.obolibrary.org/obo/MONDO_0016826) (methylmalonic acidemia with homocystinuria), [MONDO:0016625](http://purl.obolibrary.org/obo/MONDO_0016625) (rare acquired deficiency anemia), [MONDO:0016624](http://purl.obolibrary.org/obo/MONDO_0016624) (constitutional deficiency anemia), 

**Corr. equiv. classes:** [Orphanet:98396](http://www.orpha.net/ORDO/Orphanet_98396), [Orphanet:332](http://www.orpha.net/ORDO/Orphanet_332), [Orphanet:98360](http://www.orpha.net/ORDO/Orphanet_98360), [Orphanet:248296](http://www.orpha.net/ORDO/Orphanet_248296), [OMIM:300322](http://purl.obolibrary.org/obo/OMIM_300322), [Orphanet:26](http://www.orpha.net/ORDO/Orphanet_26), [Orphanet:248293](http://www.orpha.net/ORDO/Orphanet_248293), [OMIM:261000](http://purl.obolibrary.org/obo/OMIM_261000), [Orphanet:98408](http://www.orpha.net/ORDO/Orphanet_98408), [Orphanet:79283](http://www.orpha.net/ORDO/Orphanet_79283), [Orphanet:248302](http://www.orpha.net/ORDO/Orphanet_248302), [Orphanet:98415](http://www.orpha.net/ORDO/Orphanet_98415), [OMIM:277410](http://purl.obolibrary.org/obo/OMIM_277410), [Orphanet:510](http://www.orpha.net/ORDO/Orphanet_510), [Orphanet:206428](http://www.orpha.net/ORDO/Orphanet_206428), [Orphanet:622](http://www.orpha.net/ORDO/Orphanet_622), 

**Class expressions from DL-Learner:**

- [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0001263](http://purl.obolibrary.org/obo/HP_0001263) (Global developmental delay) and [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 53.32%
- [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 50.30%
- [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 50.30%
- [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 50.30%
- [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0001263](http://purl.obolibrary.org/obo/HP_0001263) (Global developmental delay) and [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 45.83%
- [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 44.12%
- [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 44.12%
- [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 41.37%
- [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0001263](http://purl.obolibrary.org/obo/HP_0001263) (Global developmental delay) 41.37%
- [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 40.24%
- [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0001263](http://purl.obolibrary.org/obo/HP_0001263) (Global developmental delay) 37.50%
- [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 36.75%
- [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) 34.86%
- [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 34.32%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 30.03%


